Centene Corporation (0HVB.L)
USD 60.85
(-6.73%)
USD 60.85
(-6.73%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 58.68 Billion USD | 8.07% |
| 2022 | 54.3 Billion USD | 2.96% |
| 2021 | 52.73 Billion USD | 20.18% |
| 2020 | 43.88 Billion USD | 55.05% |
| 2019 | 28.3 Billion USD | 42.38% |
| 2018 | 19.87 Billion USD | 32.71% |
| 2017 | 14.97 Billion USD | 5.91% |
| 2016 | 14.14 Billion USD | 182.01% |
| 2015 | 5.01 Billion USD | 473.8% |
| 2014 | 874 Million USD | 31.23% |
| 2013 | 666 Million USD | 24.37% |
| 2012 | 535.48 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 55.68 Billion USD | 0.22% |
| 2024 Q1 | 55.56 Billion USD | -7.31% |
| 2024 Q3 | 54.94 Billion USD | -1.33% |
| 2023 Q3 | 58.96 Billion USD | 3.33% |
| 2023 Q2 | 57.06 Billion USD | -1.26% |
| 2023 Q1 | 57.79 Billion USD | 6.44% |
| 2023 FY | 59.94 Billion USD | 10.39% |
| 2023 Q4 | 59.94 Billion USD | 1.66% |
| 2022 Q3 | 55.57 Billion USD | 1.97% |
| 2022 Q2 | 54.49 Billion USD | -1.76% |
| 2022 Q1 | 55.47 Billion USD | 5.18% |
| 2022 FY | 54.3 Billion USD | 2.96% |
| 2022 Q4 | 54.3 Billion USD | -2.29% |
| 2021 Q1 | 43.74 Billion USD | 164.68% |
| 2021 Q2 | 45.41 Billion USD | 3.8% |
| 2021 FY | 52.73 Billion USD | 20.18% |
| 2021 Q3 | 51.06 Billion USD | 12.46% |
| 2021 Q4 | 52.73 Billion USD | 3.27% |
| 2020 Q1 | 17.03 Billion USD | 25.9% |
| 2020 FY | 43.88 Billion USD | 55.05% |
| 2020 Q3 | 16.6 Billion USD | 0.19% |
| 2020 Q2 | 16.56 Billion USD | -2.71% |
| 2020 Q4 | 16.52 Billion USD | -0.43% |
| 2019 Q2 | 6.93 Billion USD | 2.11% |
| 2019 Q1 | 6.78 Billion USD | 1.36% |
| 2019 FY | 28.3 Billion USD | 42.38% |
| 2019 Q4 | 13.52 Billion USD | 96.78% |
| 2019 Q3 | 6.87 Billion USD | -0.81% |
| 2018 Q1 | 5.29 Billion USD | 11.43% |
| 2018 FY | 19.87 Billion USD | 32.71% |
| 2018 Q3 | 6.52 Billion USD | 1.79% |
| 2018 Q4 | 6.69 Billion USD | 2.6% |
| 2018 Q2 | 6.41 Billion USD | 21.15% |
| 2017 Q3 | 4.77 Billion USD | 0.02% |
| 2017 Q4 | 4.74 Billion USD | -0.44% |
| 2017 Q1 | 4.71 Billion USD | 0.04% |
| 2017 Q2 | 4.76 Billion USD | 1.15% |
| 2017 FY | 14.97 Billion USD | 5.91% |
| 2016 Q1 | 4.28 Billion USD | 251.89% |
| 2016 FY | 14.14 Billion USD | 182.01% |
| 2016 Q4 | 4.71 Billion USD | 25.88% |
| 2016 Q3 | 3.74 Billion USD | 2.6% |
| 2016 Q2 | 3.64 Billion USD | -14.86% |
| 2015 Q3 | 1.27 Billion USD | 11.54% |
| 2015 Q2 | 1.14 Billion USD | 1.69% |
| 2015 Q1 | 1.12 Billion USD | 28.72% |
| 2015 FY | 5.01 Billion USD | 473.8% |
| 2015 Q4 | 1.21 Billion USD | -4.55% |
| 2014 Q3 | 950.97 Million USD | 7.47% |
| 2014 Q2 | 884.89 Million USD | 9.12% |
| 2014 Q1 | 810.97 Million USD | 21.77% |
| 2014 FY | 874 Million USD | 31.23% |
| 2014 Q4 | 874 Million USD | -8.09% |
| 2013 Q4 | 666 Million USD | 28.59% |
| 2013 Q2 | 548.47 Million USD | 2.95% |
| 2013 Q3 | 517.93 Million USD | -5.57% |
| 2013 Q1 | 532.73 Million USD | -0.51% |
| 2013 FY | 666 Million USD | 24.37% |
| 2012 FY | 535.48 Million USD | 0.0% |
| 2012 Q4 | 535.48 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -48952.961% |
| Accuray Incorporated | 423.54 Million USD | -13755.736% |
| Align Technology, Inc. | 2.45 Billion USD | -2291.998% |
| Elevance Health Inc. | 69.52 Billion USD | 15.589% |
| AxoGen, Inc. | 101.16 Million USD | -57910.913% |
| Boston Scientific Corporation | 15.6 Billion USD | -276.041% |
| CVS Health Corporation | 173.09 Billion USD | 66.096% |
| Cardinal Health, Inc. | 48.33 Billion USD | -21.418% |
| DaVita Inc. | 14.87 Billion USD | -294.491% |
| HCA Healthcare, Inc. | 55.15 Billion USD | -6.408% |
| Hologic, Inc. | 4.02 Billion USD | -1357.65% |
| Humana Inc. | 30.74 Billion USD | -90.864% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -3205.462% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | -564.263% |
| Masimo Corporation | 1.67 Billion USD | -3400.03% |
| McKesson Corporation | 69.04 Billion USD | 15.001% |
| Patterson Companies, Inc. | 1.89 Billion USD | -2996.834% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | -671.765% |
| ResMed Inc. | 2 Billion USD | -2822.049% |
| Henry Schein, Inc. | 5.42 Billion USD | -982.749% |
| Teladoc Health, Inc. | 2.06 Billion USD | -2740.106% |
| Universal Health Services, Inc. | 8.15 Billion USD | -619.625% |
| Veeva Systems Inc. | 1.26 Billion USD | -4535.115% |
| Baxter International Inc. | 19.8 Billion USD | -196.269% |
| Becton, Dickinson and Company | 26.98 Billion USD | -117.481% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -2770.805% |
| Danaher Corporation | 30.99 Billion USD | -89.319% |
| Stryker Corporation | 21.31 Billion USD | -175.271% |
| Medtronic plc | 39.56 Billion USD | -48.341% |